4//SEC Filing
ANDRZEJEWSKI STEPHEN J 4
Accession 0001209191-09-004223
CIK 0001047699other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 5:40 PM ET
Size
8.9 KB
Accession
0001209191-09-004223
Insider Transaction Report
Form 4
ANDRZEJEWSKI STEPHEN J
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2008-12-31+21,060→ 142,720 total - Award
Common Stock
2009-01-16+3,823→ 146,543 total - Exercise/Conversion
Long-Term Performance Unit
2008-12-31−21,060→ 0 totalExp: 2008-12-31→ Common Stock (21,060 underlying)
Footnotes (1)
- [F1]Each Long-Term Performance Unit represented a contingent right to receive a share of King Pharmaceuticals, Inc. common stock if the reporting person remained employed by King Pharmaceuticals, Inc. during the two-year vesting period that ended on December 31, 2008.
Documents
Issuer
KING PHARMACEUTICALS INC
CIK 0001047699
Entity typeother
Related Parties
1- filerCIK 0001321648
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 5:40 PM ET
- Size
- 8.9 KB